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Objective: Our objective was to investigate the influence of preoperative 
myocardial ultrastructure and metabolism on recovery of contractile function 
after coronary artery bypass grafting in patients with coronary artery disease 
and left ventricular dysfunction. Methods: Dynamic positron emission tomog- 
raphy with 13N-ammonia and lSF-deoxyglucose was used to assess myocardial 
perfusion and glucose uptake in 53 patients cheduled for coronary revascu- 
larization because of coronary artery disease and left ventricular dysfunction. 
The degree of tissue fibrosis and the presence of potentially reversible 
alterations of cardiomyocytes (loss of myofilaments and accumulation of 
glycogen) were quantified from transmural biopsy specimens. These were 
harvested from the center of the dysfunctional rea during the operation and 
analyzed with a light microscope. The recovery of contractile performance was 
assessed from the changes in left ventricular function at contrast ventriculog- 
raphy or echocardiography before and 6 months after the operation. Results: 
According to postoperative changes in regional wall motion, left ventricular 
function was considered to have improved in 34 patients, whereas dysfunction 
persisted in 19 patients. In patients with improved wall motion, ejection 
fraction rose by 12% and end-systolic volume decreased by 28%. By contrast, in 
patients with persistent dysfunction, ejection fraction decreased by 6% and 
end-systolic volume increased by 25%. Before revascularization, myocardium 
with reversible dysfunction displayed higher levels of absolute myocardial 
blood flow, higher myocardial glucose uptake, less tissue fibrosis, and more 
altered cardiomyocytes than myocardium with persistent dysfunction. Signif- 
icant correlations were found between regional blood flow and the surface of 
the biopsy specimen covered by fibrosis, as well as between glucose uptake and 
the density of altered cardiomyocytes. Conclusion: In patients with left ventric- 
ular ischemic dysfunction, the recovery of regional and global left ventricular 
function after surgical revascularization is associated with higher preoperative 
blood flow and glucose uptake, with less tissue fibrosis and a higher amount of 
viable cardiomyocytes in the dysfunctional area. The current study thus 
confirms the value of noninvasive preoperative metabolic imaging for identi- 
fication of residual viable lnyocardium and for prediction of the functional 
outcome after revascularization. (J Thorac Cardiovasc Surg 1997;113:371-8) 
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p revious studies have shown that chronic left 
ventricular dysfunction induced by coronary ar- 
tery disease does not always result from irreversible 
tissue damage and, to some extent, can be reversed 
by coronary revascularization. 1-3 These observations 
have led to the concept of residual myocardial 
viability in which poorly contractile myocardium 
that improves in the postoperative period is deemed 
"hibernating" or "viable," whereas myocardium that 
remains dysfunctional despite revascularization is 
considered :to be infarcted or "nonviable." The 
recovery of contractile function after revasculariza- 
tion helps in important ways to reduce long-term 
mortality in patients with coronary artery disease. 4's 
Thus the preoperative identification of residual via- 
ble myocardium has commanded considerable at- 
tention and has fostered the development of several 
new modalities aimed at predicting the return of left 
ventricular function after revascularization. Because 
reversibly dysfunctional myocardium must retain 
sufficient metabolic activity to maintain basal cell 
functions, 6 simultaneous assessment of regional 
myocardial blood flow and metabolism with positron 
emission tomography (PET) has emerged as a safe, 
noninvasive, and accurate means of predicting func- 
tional recovery after revascularization. 7-9 We and 
others have recently reported on the presence of 
characteristic ultrastructural terations in ischemi- 
cally compromised myocardium and their potential 
relation to the metabolic hanges that were shown 
to occur with PET in this tissue. 1°-12 In the current 
study, we summarized the data accumulated over 
the past 5 years in 53 patients undergoing coronary 
artery bypass grafting (CABG) in whom flow and 
metabolic data, obtained with PET before the oper- 
ation, were correlated with the results of a detailed 
morphometric analysis of a transmural biopsy spec- 
imen harvested from the center of the dysfunctional 
area. Our data further substantiate he value of the 
preoperative assessment of myocardial viability for 
the prediction of postoperative improvement in left 
ventricular function. 
Methods 
Study population. The study comprised 53 patients (45 
men and 8 women, mean age 60 -- 11 years, range 27 to 75 
years) with significant left anterior descending coronary 
artery disease (defined as >75% stenosis of the luminal 
diameter) and severe anterior dysfunction. Patients were 
considered eligible for inclusion into the study if they had 
(1) severe anterior wall dysfunction at contrast cineven- 
triculography, (2) proximal left anterior descending coro- 
nary artery disease suitable for CABG, (3) complete 
revascularization f the dysfunctional rea, and (4) ab- 
sence of perioperative myocardial infarction. Thirty-seven 
patients had a previous Q-wave myocardial infarction, the 
most recent occurring 30 days before inclusion into the 
study. Six patients had type II diabetes mellitus. All 
patients underwent successful CABG at an average of 53 
days after the PET study; the left internal thoracic artery 
was used to graft the left anterior descending coronary 
artery. The study protocol was approved by the Ethical 
Committee of the University of Louvain Medical School. 
Selective coronary arteriography was performed in ev- 
ery patient at an average of 34 days before the PET study. 
A complete occlusion or a severe proximal stenosis of the 
left anterior descending coronary artery was found in each 
case. Seven patients had one-vessel disease, 15 patients 
had two-vessel disease, and 31 patients had three-vessel 
disease. Two patients also had left main stenosis. Contrast 
cineventriculography, from the 30-degree right anterior 
oblique projection, was performed in 16 patients before 
and again 6 months after revascularization to assess the 
recovery of regional and global left ventricular function. 
Left ventricular volumes at end-diastole and end-systole 
were calculated by use of Simpson's method. Regional 
wall motion was assessed in five segments (anterobasal, 
anterolateral, apical, inferior, and posterobasal) by two 
experienced observers. Each segment was defined as (1) 
normal, (2) hypokinetic, or (3) akinetic. A wall motion 
score for the segments perfused by the left anterior 
descending coronary artery was calculated by summing 
the scores of the anterobasal, anterolateral, and apical 
segments. 
Resting two-dimensional echocardiograms were ob- 
tained before and again 6 months after revascularization 
in the 37 patients who did not undergo repeated contrast 
cineventriculography. Images from the left parasternal 
short- and long-axis views and from the apical four- and 
two-chamber views were digitized on-line as previously 
described. 13Regional wall motion was assessed in 16 
segments and defined as (1) normal, (2) hypokinetic, or 
(3) akinetic. A wall motion score for the segments sup- 
plied by the left anterior descending coronary artery was 
calculated by summing the scores of the mid-anterior, 
lateral-apical, and anterior-apical segments. Left ventric- 
ular volumes at end-diastole and end-systole were calcu- 
lated from the apical four- and two-chamber views by use 
of Simpson's method. 
Follow-up. Repeated contrast ventriculography (n = 
16) or two-dimensional echocardiography (n = 37) was 
obtained 6 months after the operation. Patients were 
considered to have improvement in function after revas- 
cularization if ejection fraction increased by at least 5% 
and regional wall motion score improved by at least one 
full grade from baseline to the follow-up study. Similarly, 
patients Were considered to have persistent dysfunction if
ejection fraction did not improve, if regional wall motion 
failed to improve at follow-up, or both. 
PET. PET acquisition was performed with an ECAT 
III one-ring tomograph or an ECAT EXACT HR multi- 
slice tomograph (CTI, Knoxville, Tenn.). So that the 
dietary state would be standardized, myocardial glucose 
uptake was maximized by intravenous infusion of a 10% 
dextrose in water solution (15 tzg/kg per minute) in 13 
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Table  I. Definitions relevant o glucose metabol ism 
Metabolic concept Definition 
FDG uptake 
Mismatch pattern 
Match pattern 
Glucose uptake 
Normalized glucose uptake 
Apparent overall 18F activity in a given segment of the myocardium; always expressed in relative terms 
as percent of maximal activity at the same imaging level. 
Discordant reduction of overall evels of 18F and ~3N in a given myocardial segment of the myocar- 
dium. 
Concordant reduction of overall evels of 18F and 13N in a given myocardial segment of the myocar- 
dium. 
Absolute quantity of glucose taken up by the myocardium per unit of time; requires dynamic FDG 
imaging; expressed as txmol • (min • 100 gm) -1. 
Ratio of the absolute glucose uptake in the risk region to that in a remote normal region; expressed 
as percent of remote. 
Tab le  II. Clinical and angiographic haracteristics 
Reversible Persistent 
All dysfunction dysfunction 
(n - 53) (n = 34) (n - 19) p Value 
Age (yr) 60 _+ 11 59 _+ 12 61 _+ 11 NS 
Sex 45M, 8F  28M, 6F  17M, 2F  NS 
Anterior Q waves 37/53 20/34 17/19 0.05 
No. of diseased vessels 
One vessel 7/53 5/34 2/19 
Two or three vessels 46/53 29/34 17/19 NS 
CCS class 
I + II 40/53 26/34 14/19 
III + IV 13/53 8/34 5/19 NS 
NYHA class 
I + II 42/53 29/34 13/19 
III + IV 11/53 5/34 6/19 NS 
End-diastolic volume (ml) 199 _+ 59 184 _+ 57 228 _+ 55 0.003 
End-systolic volume (ml) 128 _+ 55 117 _+ 54 148 _+ 51 0.02 
Ejection fraction (%) 37 _+ 12 38 _+ 14 36 _+ 10 NS 
Wall motion score 7.8 _+ 1.1 7.6 -+ 1.2 8.1 _+ 0.9 NS 
ccs, Canadian Cardiovascular Society; NYHA, New York Heart Association; NS, not significant. 
patients or by use of the hyperinsulinemic-euglycemic 
glucose clamp technique 14 in the remaining 40 patients. 
Myocardial perfusion was assessed with 13N-ammonia and 
exogenous glucose uptake with 18F-deoxyglucose (FDG). 
The tracers were injected intravenously over a 30-second 
period by means of an infusion pump. One dynamic 
midventricular t ansaxial study was analyzed per patient 
for dynamic imaging. For acquisitions performed with the 
ECAT EXACT HR tomograph, this slice was obtained by 
summing four smaller slices of 3.2 mm to obtain a slice 
width comparable with that from the ECAT III tomo- 
graph (15 mm). Three large irregular volumes of interest 
were assigned to each image of the left ventricular myo- 
cardium and a circular volume of interest was assigned to 
the center of the left ventricular blood pool. One of the 
volumes of interest encompassed the interventricular sep- 
turn, another the anterior wall, and the remaining the 
lateral free wall of the left ventricle. The lateral free wall 
was considered as the remote normal segment if no 
dysfunction was present on two-dimensional echocardio- 
grams. Counts were corrected for partial volume and 
spillover effects by means of a specially developed Monte- 
Carlo simulation, 11 as well as for dead-time losses. The 
volumes of interest drawn on the FDG study were copied 
onto the 13N-ammonia study. Identical placement of the 
volumes of interest on all dynamic studies was ascer- 
tained, and manual correction for patient movement was 
done if necessary. 
13N-ammonia and ~SF-FDG cross-sectional images 
were analyzed with an operator-interactive computer pro- 
gram using circumferential profiles. 11 The program nor- 
malizes 18F and 13N counts within a given myocardial 
cross section to maximal activity in the same ventricular 
slice. Each cross section of the left ventricle was divided 
into serial 10-degree segments. Activity within each seg- 
ment was expressed in relative terms (reported as relative 
18F and 13N uptake) as percent of maximal activity. A 
pattern of flow/metabolism "mismatch" was considered to 
be present when the relative ammonia uptake was lower 
than the minimal range of the normal volunteers (70%) 11 
and when the FDG/ammonia ratio exceeded 1.2. For 
this analysis, the activity was normalized to peak 13N- 
ammonia activity. PET data were quantified as previously 
described.11, is Regional myocardial perfusion was quan- 
374 Deprd et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
February 1997 
250 
200 
= 150 
o 
100 
50 
A 
60 
40 
o 
20 
. ~  
, B 
I I I 1 
PRE POST PRE POST 
Fig. 1. End-systolic volume (A) and ejection fraction (B) in patients with reversible (closed circles) and 
persistent (open circles) dysfunction before the operation (PRE) and at follow-up (POST). *p < 0.05. 
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acid-Schiff reaction were prepared for each sample. Light 
microscopy was used to quantify cellular alterations 
(mainly the loss of myofibrils and the percentage of 
intracellular volume occupied by glycogen) and the 
amount of extracellular matrix. 12'17 Each section was 
examined by means of quantitative morphometry as pre- 
viously described. 12' 17 This procedure was repeated sev- 
eral times on different zones of the biopsy specimen. 
Statistical analysis. Values are expressed as mean _+ 
one standard eviation. Differences in discrete variables 
between patients with and without recovery were com- 
pared by means of X z tests, whereas those in continuous 
variables were compared by use of the Student's t test for 
unpaired data. The correlation between PET and mor- 
phometric parameters was investigated by use of linear 
regression analysis. All p values less than 0.05 were 
considered indicative of a statistically significant differ- 
ence. 
Fig. 2. Bar graph showing the percentage of surface of 
the biopsy specimen covered by fibrosis (left) and abnor- 
mal cardiomyocytes (righO in patients with reversible and 
persistent dysfunction (mean -+ standard eviation). *p < 
0.05. 
tiffed by use of a three-compartment model, is and the 
Patlak graphic analysis was used to estimate myocardial 
glucose uptake. 16 The different parameters of flow and 
glucose metabolism measured at PET are described in 
Table I. 
Morphologic analysis. One transmural biopsy speci- 
men (20 mm 14-gauge needle) was obtained from the 
dysfunctional region before induction of extracorporeal 
circulation. The samples were immediately fixed in 3% 
glutaraldehyde buffered at pH 7.4, then postfixed in 
osmium tetroxide and embedded in Epon fixative.l° Semi- 
thick sections stained with toluidine blue and periodic 
Results 
According to the changes in left ventricular ejec- 
tion fraction and regional wall motion score at 
follow-up, 34 patients were considered to have 
functional improvement, whereas 19 patients were 
considered to have persistent dysfunction. The clin- 
ical characteristics of these two groups of patients 
are shown in Table II. The two groups were compa- 
rable with respect o age, sex, extent and severity of 
coronary artery disease, and extent of left ventricu- 
lar dysfunction. Previous myocardial infarction was 
more prevalent in patients with persistently dysfunc- 
tional myocardium. Such patients also had larger 
end-systolic and end-diastolic volumes (see Table 
II). Fig. 1 shows the changes in ejection fraction and 
left ventricular volumes resulting from coronary 
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Table IlL PET and morphologic haracteristics 
Reversible Persistent 
All  dysfunction dysfunction 
(n = 53) (n = 34) (n = 19) p Value 
Myocardial blood flow 81 + 21 90 +_ 29 63 _+ 20 0.002 
(ml • [rain • 100 gin] 1) 
Percent ammonia uptake 67 _+ 17 71 _+ 15 58 _+ 17 0.01 
Myocardial glucose uptake 37 _+ 17 42 + 16 30 _+ 14 0.01 
(t,tool' [rain • 100 gin] 1) 
Percent FDG uptake 72 _+ 20 77 _+ 19 62 _+ 17 0.01 
FDG/ammonia 1.25 + 0.31 1.21 _+ 0.30 1.32 _+ 0.33 NS 
Percent issue fibrosis 27 +_ 16 24 _+ 15 37 _+ 19 0.003 
Percent altered cardiomyocytes 35 + 16 38 _+ 15 29 _+ 18 NS 
NS. Not significant. 
revascularization in the two groups of patients. Left 
ventricular ejection fraction increased by 12% _+ 7% 
in patients with reversible dysfunction and de- 
creased by 6% + 9% in patients with persistent 
dysfunction. Similarly, end-systolic volume de- 
creased by 29 ± 21 ml in patients with reversible 
dysfunction and increased by 27 ± 31 ml in those 
with persistent dysfunction. 
The PET and morphologic characteristics of the two 
groups of patients are summarized in Table III. Re- 
versibly dysfunctional segments showed higher levels 
of absolute and relative myocardial blood flow and 
glucose uptake than segments with persistent dysfunc- 
tion. They also had a lesser increase in extracellular 
matrix and tended to show more altered cardiomyo- 
cytes and glycogen accumulation. Similar results were 
obtained in the subgroups of patients with an initial 
ejection fraction less than 30%. 
As shown in Fig. 3, significant correlations were 
observed between the amount of extracellular ma- 
trix and both absolute (A) and relative (B) levels of 
regional myocardial blood flow. Similarly, absolute 
regional myocardial glucose uptake correlated with 
the density of altered cardiomyocytes (Fig. 4,A) and 
with the amount of glycogen accumulated in these 
cells (Fig. 4, B). There was no significant correlation 
between relative FDG uptake and the morphologic 
characteristics. 
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Discuss ion  
Each year in the United States, more than 200,000 
patients undergo CABG. Although this intervention 
can improve symptoms and lessen disability in al- 
most every patient, it probably confers the greatest 
advantages and prolongs urvival in the subgroup of 
patients with severe depression of left ventricular 
function. 2Innovations in operative techniques, myo- 
cardial protection, and postoperative care have un- 
doubtedly contributed in important ways to these 
outstanding results. Yet not every patient with cor- 
onary artery disease does benefit from surgical 
revascularization, for CABG continues to entail 
significant immediate risks, particularly when global 
left ventricular function is severely depressed. Care- 
ful selection of individual patients with left ventric- 
ular dysfunction for surgical revascularization is 
therefore mandatory. The present study shows that 
the recovery of regional contractile function after 
CABG correlates significantly with preoperative 
myocardial perfusion and glucose uptake by PET; it 
correlates as well with the extent and severity of 
morphologic changes in the underlying tissue, 
mainly fibrosis and the amount of structurally al- 
tered cardiomyocytes. These data thus further sub- 
stantiate the value of metabolic imaging with PET in 
the preoperative selection of patients with left ven- 
tricular dysfunction for CABG. 
Previous clinical studies have shown that chronic 
regional dysfunction caused by coronary artery dis- 
ease does not always result from irreversible tissue 
damage and, to some extent, can be reversed by 
restoration of blood flow. 13' 28-20 The current study 
confirms and extends these earlier reports. In this 
study, regional and global left ventricular function 
improved significantly in 34 of the initial 53 patients 
after revascularization a d remained depressed in 
only 19 patients. In addition, our data indicate that 
the degree of improvement in left ventricular func- 
tion after adequate revascularization is dependent 
on the severity of preexisting irreversible tissue 
damage. Segments with persistent postoperative 
dysfunction indeed showed almost twice as much 
tissue fibrosis and contained fewer metabolically 
active and thus viable cardiomyocytes than segments 
with reversible dysfunction. Obviously, revascular- 
ization of such fibrotic, myocyte-depleted segments 
is unlikely to reverse the underlying structural ab- 
normalities and to restore contraction. Interestingly 
enough, the structural characteristics of both revers- 
ibly and irreversibly damaged myocardium were 
found to correlate significantly with the PET flow 
and metabolic findings. Specifically, the extent of 
tissue fibrosis correlated with both absolute and 
relative levels of myocardial blood flow, whereas the 
density of altered cardiomyocytes correlated with 
the amount of myocardial glucose or FDG uptake. 
This suggests that these two parameters (tissue 
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fibrosis and the density of altered cardiomyocytes) 
are the structural basis underlying the ability to 
predict functional recovery by the measurement of
residual tissue perfusion and glucose uptake by 
PET. 
The current study confirms the presence of 
structurally altered cardiomyocytes in ischemi- 
cally jeopardized myocardium. The morphologic 
features of these cells have been described else- 
where.l~, 12, 17 At present, the mechanisms leading 
to their occurrence remain poorly understood and 
are at best sketchy. However, there is increasing 
evidence that these mechanisms could be the 
consequence of a dedifferentiation process, inas- 
much as their phenotype closely resembles that of 
fetal cardiomyocytes. 21 
This study has several limitations, which have 
already been acknowledged. The relation between 
the structural alterations een with the microscope 
and the findings with PET requires much caution, 
particularly in view of the small size of the biopsy 
samples, which was imposed by safety consider- 
ations. One must nonetheless assume that the mor- 
phologic alterations were evenly distributed in the 
area of interest--not necessarily true in patients 
with a previous infarction. Also, the fact that preop- 
erative studies were performed ays to weeks before 
the operation and that postoperative studies oc- 
curred months after the operation raises the possi- 
bility that intervening events could have influenced 
the outcome in individual patients. This is unlikely, 
however, because none of the patients had any 
adverse vents before the operation or between the 
operation and the postoperative follow-up studies. 
Finally, the current study does not allow us to 
determine whether structural reversibility contrib- 
utes to the functional improvement after revascular- 
ization. For obvious ethical reasons, it has not yet 
been possible to obtain a second surgical biopsy 
specimen at a distance from the revascularization 
procedure and to test this hypothesis. 
Conclusions 
We have described the structural, flow, and met- 
abolic correlates of the recovery of contractile func- 
tion after revascularization in patients with chronic 
ischemic anterior wall dysfunction. The data show 
that the recovery of regional contraction is related 
to the extent and severity of tissue fibrosis, to the 
density of metabolically active cardiomyocytes, and 
to resting myocardial blood flow and glucose uptake. 
The PET studies were performed with the help of C. 
Michel, T. Baudhuin, and C. Grandin. Radiopharmaceu- 
ticals were prepared by D. Labar and M. Cogneau. The 
morphologic studies were prepared by F. Thon6. Their 
expertise is greatly appreciated. We are indebted to A. 
Robert, PhD, consultant statistician, for reviewing the 
statistical analysis. 
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Discuss ion 
Dr. L. Henry Edmunds, Jr. (Philadelphia, Pa.). Because 
these are patients, you probably knew the ejection frac- 
tions before and after the operation. How many of the 40 
patients had an improvement of 5% or more in their 
ejection fraction after the operation and how well did that 
correlate with your assay and with the PET scan? 
Dr. Dion. By definition--according to the design of this 
study--all of the patients in the "viable" group (34/53) bad 
an improvement by at least 5% in their ejection fraction 
after the operation. The correlation between PET scan 
prediction of recovery and functional recovery was as 
follows: considering FDG alone and a "cutoff" of 60%, the 
sensitivity was 88% and the specificity 50%; considering 
flow alone and a "cutoff" of 64 ml/min per 100 gin, the 
sensitivity was 91% and the specificity 56%; finally, con- 
sidering the mismatch and a "cutoff" of flow/FDG less 
than 1:2, the sensitivity was only 66% and the specificity 
44%. Therefore, to improve the prediction of functional 
recovery provided by the PET scan, namely its specificity, 
we need another noninvasive tool in the preoperative 
period, ideally, stress echocardiography. 
Dr. Edward D. Verrier (Seattle, Wash.). Dr. Buckberg, 
last year your group published a significant article in 
Circulation concerning the mismatch between flow and 
metabolism. You were able to devise a scale that quanti- 
tared the expected percent of recovery that may be 
achieved by using a PET scan with the myocardial viability 
index of the deoxyglucose. How does that fit into this 
assessment, in which there is not so much of a correlation 
between the flow and metabolism? 
Dr. Gerald D. Buckberg (Los Angeles, Calif.). The study 
at UCLA showed an approximately 80% improvement in
function with a mismatch between flow and deoxyglucose. 
The greatest improvement occurred when there was a 
large mismatch (->18%) with 107% improvement, com- 
pared with minimum recovery (approximately 34%) with 
minimal or no PET mismatch (<-5%). Consequently, the 
largest mismatch showed the greatest clinical benefit. 
Dr. Verrier. Dr. Dion, how many patients of your group 
were actually referred for transplantation but were instead 
treated by revascularization the basis of the results of 
this technology? 
Dr. Dion. None of these patients was ever considered 
for heart transplantation. Every patient with an ejection 
fraction less than 35% undergoes an extensive battery of 
viability tests, namely, dobutamine stress echocardiogra- 
phy, thallium scintigraphy with reperfusion, and PET 
scan. If viability is detected and some functional recovery 
anticipated, we always attempt myocardial revasculariza- 
tion first. 
Dr. James K. Kirklin (Birmingham, Ala.). In using this 
as a prognostic test in deciding who would benefit from 
revascularization, how did you separate out the possibility 
of loss of cell viability during the operation? How did you 
separate out the possibility of losing cells in the operating 
room, that is, of imperfect myocardial protection? Is that 
a possibility that that would influence the results of your 
viability testing? 
Dr. Dion. Predicting the relative quality of the periop- 
erative myocardial protection, even when based on the 
preoperative coronary angiogram, looks hazardous to me. 
Theoretically, the combination of antegrade and retro- 
grade cardioplegia should optimally protect he myocar- 
dium even in the presence of a diffuse triple-vessel 
disease. In our series, the cardiac enzymes were measured 
every 4 hours after the operation, and the enzyme curves 
were flat. There was no pathologic hange in the electro- 
cardiogram. Also, the internal thoracic artery graft to the 
left anterior descending coronary artery was patent at 
angiographic restudy in all patients. Finally, no cardiac 
adverse vents occurred between the operation and the 
time of assessment of cardiac function. Therefore I be- 
lieve that the prognostic value of our viability testing was 
not influenced by intercurrent perioperative alterations. 
Dr. Verrier. The question that remains is when to use 
this sort of expensive technology to determine viability. 
The combination of these tests can cost in excess of a 
number of a thousand ollars. Certainly at the University 
of Washington we use them, but rarely, and almost always 
in patients with ejection fractions of 20%, in whom we are 
trying to distinguish between transplantation a d revascu- 
larization. 
